Tail length and E525K dilated cardiomyopathy mutant alter human β-cardiac myosin super-relaxed state
Authors:
- Sebastian Duno-MirandaSDSebastian Duno-Miranda
- Shane R. NelsonSNShane R. Nelson
- David V. RasicciDavid V. Rasicci
- Skylar M.L. BodtSkylar M.L. Bodt
- Jr Joseph A. CiriloJCJr Joseph A. Cirilo
- Duha VangDVDuha Vang
- Sivaraj SivaramakrishnanSSSivaraj Sivaramakrishnan
- Christopher M. YengoCYChristopher M. Yengo
- David M. WarshawDWDavid M. Warshaw
Open Access
- 6 May 2024
- journal article
- research article
- Published by Rockefeller University Press in Journal of General Physiology
- Vol. 156 (6)
Abstract
Dilated cardiomyopathy (DCM) is a condition characterized by impaired cardiac function, due to myocardial hypo-contractility, and is associated with point mutations in β-cardiac myosin, the molecular motor that powers cardiac contraction. Myocardial function can be modulated through sequestration of myosin motors into an auto-inhibited “super-relaxed” state (SRX), which may be further stabilized by a structural state known as the “interacting heads motif” (IHM). Here, we sought to determine whether hypo-contractility of DCM myocardium results from reduced function of individual myosin molecules or from decreased myosin availability to interact with actin due to increased IHM/SRX stabilization. We used an established DCM myosin mutation, E525K, and characterized the biochemical and mechanical activity of wild-type and mutant human β-cardiac myosin constructs that differed in the length of their coiled-coil tail, which dictates their ability to form the IHM/SRX state. We found that short-tailed myosin constructs exhibited low IHM/SRX content, elevated actin-activated ATPase activity, and fast velocities in unloaded motility assays. Conversely, longer-tailed constructs exhibited higher IHM/SRX content and reduced actomyosin ATPase and velocity. Our modeling suggests that reduced velocities may be attributed to IHM/SRX-dependent sequestration of myosin heads. Interestingly, longer-tailed E525K mutants showed no apparent impact on velocity or actomyosin ATPase at low ionic strength but stabilized IHM/SRX state at higher ionic strength. Therefore, the hypo-contractility observed in DCM may be attributable to reduced myosin head availability caused by enhanced IHM/SRX stability in E525K mutants.Keywords
All Related Versions
Funding Information
- American Heart Association (23PRE1013839)
- National Institutes of Health (HL150953, HL163585)
- National Science Foundation (GRFP2237827)
- Arnold and Mariel Goran
This publication has 53 references indexed in Scilit:
- Mechanisms of Sarcomere Protein Mutation-Induced CardiomyopathiesCurrent Cardiology Reports, 2023
- The mesa trail and the interacting heads motif of myosin IIArchives of Biochemistry and Biophysics, 2020
- Hypertrophic Cardiomyopathy: The Future of TreatmentEuropean Journal of Heart Failure, 2020
- Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutationsPflügers Archiv - European Journal of Physiology, 2019
- Patterning protein complexes on DNA nanostructures using a GFP nanobodyProtein Science, 2016
- Review: The ATPase mechanism of myosin and actomyosinBiopolymers, 2016
- The myosin power strokeCell Motility, 2002
- [33] Assays for actin sliding movement over myosin-coated surfaces1991
- Myosin step sizeJournal of Molecular Biology, 1990
- [18] Purification of muscle actin1982